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 Larger PGV is associated with higher levels of DHEA/S, independent of age. 
 Findings suggest early adrenarche is associated with larger PGV. 
 Larger PGV is associated with social anxiety symptoms in children. 
 PGV may mediate the association between early adrenarche and social anxiety. 
 
Abstract 
Early timing of adrenarche, associated with relatively high levels of dehydroepiandrosterone 
(DHEA) and its sulphate (DHEA-S) in children, has been linked with mental health 
problems, particularly anxiety. However, little is known about possible neurobiological 
mechanisms underlying this association. The pituitary gland is a key component of the 
hypothalamic-pituitary-adrenal (HPA) axis, the activation of which triggers the onset of 
adrenarche. The purpose of this study was to examine the extent to which pituitary gland 
volume mediated the relationship between levels of DHEA/DHEA-S relative to age (i.e., 
adrenarcheal timing) and symptoms of anxiety in 95 children (50 female, M age 9.50 years, 
SD 0.34 years). Relatively high DHEA and DHEA-S (DHEA/S) levels were found to be 
associated with larger pituitary gland volumes. There was no significant direct effect of 
relative DHEA/S levels on overall symptoms of anxiety. However, results supported an 
indirect link between relatively high DHEA/S levels and symptoms of social anxiety, 
mediated by pituitary gland volume. No sex differences were observed for any relationship. 
Our findings suggest that neurobiological mechanisms may be partly responsible for the link 
between relatively early adrenarche and anxiety symptoms in children. One possible 
mechanism for this finding is that an enlarged pituitary gland in children experiencing 
relatively advanced adrenarche might be associated with hyper-activity/reactivity of the HPA 
axis. Further research is needed to understand the role of stress in the link between 
adrenarcheal timing and HPA-axis function, especially in relation to the development of 
anxiety symptoms in children and adolescents. 
 





Individual differences in the timing of puberty (i.e., the stage of puberty of the 
individual relative to their same-aged peers) can confer vulnerability to adverse mental health 
outcomes, particularly mood and anxiety disorders. These disorders show a dramatic rise in 
incidence during the early to mid-adolescent phase (Ge & Natsuaki, 2009; Patton & Viner, 
2007). Indeed, early maturation of the hypothalamic-pituitary-gonadal (HPG) axis (i.e., early 
timing of gonadarche) constitutes a significant risk factor for the development of mental 
illness, particularly in girls (Ge, Conger, & Elder, 1996).  
The timing of adrenarche, an early maturational phase of puberty occurring prior to 
gonadarche (characterized by a marked increase in the production of the adrenal androgen 
dehydroepiandrosterone [DHEA], and its sulphate DHEA-S), also predicts adverse mental 
health problems in children. Girls and boys with premature adrenarche (i.e., pubarche before 
age 8 in girls and 9 in boys, associated with increased DHEA/S levels) demonstrate increased 
levels of anxiety and behavioral problems when compared to their later developing peers 
(Dorn, Hitt, & Rotenstein, 1999; Dorn et al., 2008; Sontag-Padilla et al., 2012). The link 
between premature adrenal development and increased risk for anxiety disorders is of 
particular interest, given that such disorders have a high incidence in this age group (Albano, 
Chorpita, & Barlow, 2003; Bernstein, Borchardt, & Perwien, 1996; Dorn et al., 1999).  
It has been suggested that the action of pubertal hormones on the development of 
cognitive and affective systems in the brain during sensitive periods may provide some 
explanation for dysregulated affect and behavior, and associated psychopathology during 
puberty (Blakemore, Burnett, & Dahl, 2010). Thus, the effect of early exposure to pubertal 
hormones on developmentally immature brain systems is postulated to contribute to the link 
between early pubertal timing and vulnerability to psychopathology. Indeed, we have 
recently provided the first evidence that early timing of adrenarche may be associated with 
alterations in brain structure and function. Specifically, we have found that relatively high 
levels of DHEA in older children was associated with reduced frontal white matter volume 
(Klauser et al., 2015), decreased affect-related brain activity in the cingulate cortex, and 
decreased affect-related brain activity in a number of cortical and subcortical regions 
(specifically in females, Whittle et al., 2015). 
Investigation of the structure of the pituitary gland might be a particularly fruitful 
approach to understanding the link between early adrenarche and anxiety in children. The 
hypothalamic-pituitary-adrenal (HPA) axis regulates and secretes the adrenal androgens 
(DHEA/S, Styne & Grumbach, 2011). The pituitary gland is an integral part of the HPA and 
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HPG axes, which become reactivated during puberty and underlies the development of 
reproductive maturity (Styne & Grumbach, 2011). The volume of the pituitary gland (PGV) 
has previously been utilized as an index of stress-related HPA-axis function (Axelson et al., 
1992), as it is thought to increase with the number of corticotrope cells producing ACTH, 
which stimulate the release of cortisol by the adrenal cortex (Pariante et al., 2004). Indeed, 
PGV has been associated with cortisol measures of HPA-axis hyper-activity and hyper-
reactivity (Kaess et al., 2013), and with early life stress (Ganella et al., 2015). PGV has also 
been used as a measure of HPG axis function (Whittle et al., 2012). Importantly, the size of 
the pituitary gland has also been associated with vulnerability to psychopathology 
(MacMaster & Kusumakar, 2004; MacMaster et al., 2006), and particularly anxiety 
symptoms and related disorders (Thomas & De Bellis, 2004). Given the role of the pituitary 
gland in adrenarche, its volume is also likely to be influenced by the action of adrenal 
hormones during adrenarche. The association between PGV and adrenarcheal processes, 
however, has currently not been investigated. Thus, given that adrenarcheal timing has been 
associated with risk for anxiety disorders (as stated above), it is plausible that PGV may play 
a role in the link between adrenarcheal timing and such risk.  
No studies to date have explored the associations between timing of adrenarche, PGV, 
and psychopathology during the developmentally sensitive period of late childhood. Given 
independent support for the roles of both adrenarcheal timing and enlarged PGV in the 
experience of anxiety, we investigated whether PGV mediated the link between timing of 
adrenarche (as assessed by adrenal hormone levels) and symptoms of anxiety in children, and 
whether this effect differed between females and males. We hypothesized that relatively early 
adrenarche (defined here as high DHEA/S levels relative to same age peers) would be 
associated with larger PGV, and that larger PGV would mediate the link between early 
adrenarche and increased symptoms of anxiety. Given consistent support for sex differences 
in the effects of gonadarcheal timing on psychopathology (Hyde, Mezulis, & Abramson, 
2008), we hypothesized that relatively high DHEA/S levels would have differential effects on 
PGV and symptoms of anxiety in females and males. However, given that sex differences in 
research on adrenarche and mental health are mixed, this aim was exploratory and we did not 
have specific hypotheses related to sex differences. Finally, we conducted exploratory 
analyses to examine the association between DHEA/S, PGV, anxiety and cortisol, in order to 
provide some comment on stress-related mechanisms that may underlie associations found 
between the primary variables of interest.   
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2. Material and methods 
2.1. Participants  
Participants were part of a nested brain-imaging project (iCATS) in the Childhood to 
Adolescence Transition Study (CATS) (Mundy et al., 2013), a longitudinal study of puberty 
and health in approximately 1200 children. A detailed description of iCATS methods can be 
found in Simmons et al. (Simmons et al., 2014). Briefly, 128 9-year old children participated 
in iCATS, and were selected based on plotting the morning DHEA and testosterone levels 
(which were highly correlated) of the participants in the CATS study, and selecting those 
children falling in the lower and upper tertiles for participation in the iCATS study. The 
purpose of this selection was to obtain a sample of female and male children who varied in 
their exposure to adrenal androgens, taking those who were comparatively advanced in their 
adrenal maturation and comparing them to a group where the hormone changes associated 
with adrenarche were not yet noticeably underway. The upper and lower tertile groups were 
intentionally matched for age to maximize the ability to infer the effects of relative timing of 
exposure to adrenal hormones (i.e., timing of adrenarche) independent of chronological age. 
Participants with a body mass index (BMI) in the upper and lower 5th percentiles were 
excluded. Physical signs of pubertal development were not included in the selection process 
because very few parents reported any physical signs of note in their children during the 
CATS assessment, as expected at age 9. Of the 128 iCATS participants, 100 agreed to 
undergo Magnetic Resonance Imaging (MRI). Ethics approval was granted by the Royal 
Children’s Hospital (RCH) Human Research Ethics Committee and ratified by the University 
of Melbourne Human Research Ethics Office. Informed consent was obtained from all 
children and parents prior to participation. 
Data from 95 participants (45 males, M age 9.6, SD 0.4 years; 50 females, M age 9.4, 
SD 0.3 years) were included in analyses after exclusions based on image acquisition 
problems and excessive motion (n = 5).  
 
2.2.Procedure  
Approximately 6 months (M 6.4, SD 1.8 months) after their participation in CATS, 
participants (as part of iCATS) underwent a 30-minute Magnetic Resonance Imaging (MRI) 
scan of the brain, assessment of salivary and hair hormones, height and weight 
measurements, a brief assessment of self-reported psychological symptoms, and a parent 
report of Tanner Stage.  
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2.3. Measures  
2.3.1. Neuroimaging.  
Approximately 6 months after recruitment to the iCATS study, participants were 
scanned using a research-dedicated 3T Siemens TIM Trio scanner (Siemens, Erlangen, 
Germany) at the Murdoch Childrens Research Institute (MCRI), RCH, Melbourne. 
Participants completed a T1-weighted MPRAGE scan that provided high-resolution images 
for structural analysis. For all scans, participants were positioned comfortably in a supine 
orientation with their head located in a 32-channel head RF coil that was electrically isolated 
from the participant. T1-weighted image parameters were: TR = 1900 ms, TE = 2.24 ms, flip 
angle = 9°, FOV = 230mm, producing 208 0.9mm contiguous sagittal slices (voxel 
dimensions = 0.9mm3).  
2.3.2. Estimation of pituitary volume.  
PGV was ascertained by manual tracing, which was performed by author CM on each 
individual’s images using the software package ANALYZE (Mayo Clinic, Rochester, USA; 
http://www.mayo.edu/research/labs/biomedical-imaging/software/analyze-software-system). 
The pituitary gland was defined and quantified based on the technique described in Pariante 
et al. (2004). Images were traced in the coronal plane, where the pituitary gland is best 
identified (Figure 1) (Pariante et al., 2004), and the infundibular stalk was excluded from 
tracing. Boundaries of the pituitary could be clearly defined by the diaphragm sellae, 
superiorly; the sphenoid sinus, inferiorly; and the cavernous sinuses, bilaterally (Pariante et 
al., 2004). Pituitary volume estimates were calculated by summing all voxels within the 
traced region on each slice to give values in mm3. Prior to tracing, reliability was established 
by comparison between CM and a researcher experienced in pituitary gland delineation. 
Intraclass correlation coefficients (absolute agreement) for intra and inter-rater reliabilities, 
assessed on ten independent randomly selected images, were 0.976 and 0.985, respectively. 
 
-- insert Figure 1 about here -- 
 
2.3.3. Anxiety symptoms.  
Children completed an assessment of self-reported anxiety symptoms using the 
Spence Children’s Anxiety Scale (SCAS) (Spence, 1998). The SCAS is a self-report 
questionnaire designed to measure the severity of anxiety symptoms in children, broadly in 
line with the dimensions of anxiety disorders proposed by the DSM-IV-TR. The scale 
assesses six domains of anxiety: generalized anxiety, panic/agoraphobia, social phobia, 
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separation anxiety, obsessive-compulsive disorder, and physical injury fears. The 
questionnaire contains 44 items, of which 38 reflect specific symptoms of anxiety, and 6 are 
positive, filler items, included to reduce negative response bias (Spence, 1998). Participants 
were asked to rate the degree to which they experience each symptom on a 4-point Likert 
scale involving never (0), sometimes (1), often (2), and always (3). Separate scores for each 
subscale are computed by summing individual item scores for questions relating to specific 
domains of anxiety.  Higher total and subscale scores indicate greater symptoms of anxiety. 
The SCAS has strong evidence for reliability and validity (Muris, Merckelbach, Ollendick, 
King, & Bogie, 2002). In the current study, the scale showed good internal consistency (α = 
.78).  
2.3.4. Adrenal development (adrenarche).  
Children were asked to provide two waking saliva samples; one on the morning prior 
to, and the second on the morning of their MRI scan, with the help of their parent/guardian. 
Samples were assayed for levels of testosterone, DHEA and DHEA-S, as hormonal markers 
of adrenal development (adrenarche). Hormonal assays were conducted at the MCRI, using 
Salimetrics ELISA kits. Participants returned their saliva samples at the time of their RCH 
visit. Samples were centrifuged and the supernatant was used in the assays. The range of 
sensitivity was from 10.2 to 1000 mg/ml. The inter-assay coefficient of variation (CV) was 
5.45% for DHEA, 7.53% for DHEA-S and 13.54% for testosterone, and intra-assay CVs 
were 8.56% for DHEA, 9.38% for DHEA-S, and 7.32% for testosterone. The mean of the 
two DHEA/S and testosterone levels in the saliva samples was used in subsequent analysis.  
2.3.5. Physical maturation.  
Tanner Stage was assessed via parent report of pubertal development using the Sexual 
Maturity Status line drawing instrument, which has demonstrated good internal consistency, 
reliability and validity (Morris & Udry, 1980).  
2.3.6. BMI.  
Two independent measures of height (to nearest 0.1 cm) and weight (to nearest 0.1 
kg) were obtained and averaged, and used to calculate a body mass index (BMI) for each 
participant. 
2.3.7. Cortisol 
 A measure of chronic systemic cortisol was obtained from a scalp hair sample. 
Cortisol was assayed in hair samples in the current study to overcome the inherent difficulties 
in interpreting point measures of cortisol from saliva (i.e., point samples vary as a function of 
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circadian rhythmicity and are susceptible to confounding by unmeasured environmental 
factors). Hair samples were collected from an area approximately 1cm2 on the posterior 
vertex of the scalp. Hair samples were not collected where <3 cm of hair length was 
available, to minimize cosmetic impact, and thus fewer males participated than females (11 
and 43, respectively, in the current sample). HCC assays were conducted by Stratech 
Scientific, where samples were cut down to 3cm lengths, and processed and assayed using 
Salimetrics ELISA kits (sensitivity <0.007μg/dL) with 50mg samples (see Simmons et al., In 
Press for further details). 
2.4. Statistical Analysis 
Data were entered into SPSS version 21 (IBM Corp, 2012). An alpha level of .05 was 
used for all statistical tests unless stated otherwise. 
2.4.1. Descriptive statistics.  
Univariate comparisons between males and females, and between Tanner Stage 1 and 
Tanner Stage 2/3, for mean scores on each measure were performed using independent 
groups t-tests. Bivariate correlations between all continuous variables were calculated 
(Pearson r). Pituitary volumes, all hormone measures (testosterone, DHEA, DHEA-S and 
cortisol), BMI, and SCAS total and subscale scores were positively skewed, and were log 
transformed to normalize distributions.  
2.4.2. Mediation analysis.  
Two initial mediation analyses were performed to test hypotheses. For the first, SCAS 
total score was the outcome variable (DV), with DHEA as the independent variable (IV). For 
the second, SCAS total score was the outcome variable, and DHEA-S was the independent 
variable. All analyses were performed using macros developed by Preacher and Hayes 
(2004). Mediation was tested by assessing the significance of the cross product of the 
coefficients for the IV (DHEA/S) to mediator (pituitary volume) relation (the a path), and the 
mediator to DV (anxiety symptoms) relation, controlling for the IV (the b path). The a-b 
cross product tests the statistical significance of the difference between the total effect (c 
path), and the direct effect (c’ path), which is the impact of the IV on the DV, adjusting for 
the effect of the mediator. See Figure 2 for an illustration of a simple mediation model. Age, 
BMI, and sex were used as covariates in both models.  
 
-- insert Figure 2 about here -- 
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Because mediation requires significant associations between both the IV and the 
mediator (the a path), and the mediator and the DV (the b path), two further exploratory 
mediation analyses were conducted after results from the bivariate correlation analyses 
revealed significant associations between pituitary volume and the SCAS social anxiety 
subscale. In these models, SCAS social anxiety scores were used as the outcome variable, 
and DHEA/S were IVs. Age, BMI and sex were once again used as covariates in both 
models. In further analyses, sex was tested as a moderator of the mediation effect of PGV on 
DHEA/S and symptoms of anxiety.  
In all analyses, a bootstrapping method was applied to test the significance of the 
mediation effect (Preacher & Hayes, 2004). Rather than imposing the distributional 
assumptions required in parametric analyses, bootstrapping generates an empirical 
approximation of the sampling distribution of a statistic by repeated random resampling from 
the available data, and uses this distribution to calculate p values and construct bias-corrected 
and accelerated confidence intervals (for these analyses, 5000 resamples were taken, and 
95% confidence intervals were used) (see Hayes, 2009, for details). In these analyses, 
mediation is significant at the level indicated (p < .05) if the confidence intervals for the 
indirect effect do not contain zero.  
This method has advantages over Baron and Kenny’s (1986) approach, which fails to 
provide a specific test of the indirect effect of the IV on the DV through a proposed mediator. 
Further, this method allowed a test for significant mediation in the absence of a direct effect 
of the IV on the DV, which has been argued to be a possible, if not common, scenario 
(Hayes, 2009). This result is feasible because a total effect is the sum of many different paths 
of both direct and indirect influence, not all of which may be included in the formal model. 
In order to exclude the possibility that any associations found were due to an effect of 
physical signs of maturation (potentially indicative of early gonadarche), all analyses were re-
run using Tanner stage as a covariate. Testosterone was also included in further models to 
assess the specificity of findings for DHEA/S. Finally, exploratory partial correlations 
between all variables of interest and cortisol (controlling for BMI and age) were performed to 




3.1. Characteristics of Sample 
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Descriptive statistics for all continuous variables are shown in Table 1. Seventy 
percent of females, and 69% of males were in Tanner Stage 1, 24/22% of females and males 
were in Tanner Stage 2, and 4/2% of females and males were in Tanner Stage 3. Independent 
samples t-tests revealed that boys had higher BMIs, were older, and had lower scores on the 
Physical Injury subscale of the SCAS, and had higher cortisol levels. Tanner Stage did not 
differ between males and females (Χ2 = 0.22 (2), p = 0.90). PGV did not differ between the 
sexes, consistent with other research in children of a similar age (MacMaster et al., 2007). 
Independent samples t-tests showed that participants in Tanner Stage 1 versus Stage 2 or 3 
had lower BMI (p = 0.013), lower DHEA (p = 0.021), and higher obsessive-compulsive 
disorder symptoms (p = 0.045). 
 
-- insert Table 1 about here -- 
 
3.2. Correlations 
Bivariate correlations for all continuous variables are presented in Table 2. DHEA, 
DHEA-S and testosterone were significantly associated with one another, as well as with 
PGV and BMI. Total scores on the SCAS were not significantly associated with any of the 
hormone measures, or PGV. However, a significant positive association was demonstrated 
between scores on the Social Anxiety subscale of the SCAS and PGV.  
-- insert Table 2 about here – 
 
3.3. Mediation Analyses 
When controlling for age, sex, and BMI, higher levels of DHEA and DHEA-S were 
associated with larger pituitary volumes (paths a; DHEA: B = .040, SE = .018, t = 2.21, p = 
.030; DHEA-S: B = .046, SE = .016, t = 2.97, p = .004). However, PGV was not 
significantly associated with symptoms of anxiety (paths b; p’s > 0.49), nor was there a 
significant mediation effect in either model (i.e., the a b cross-products were not significant, 
as indicated by the 95% confidence intervals containing zero). 
Given the significant correlation between PGV and scores on the Social Anxiety 
subscale of the SCAS (Table 2), further exploratory mediation analyses were performed 
using symptoms of social anxiety as the outcome variable. When controlling for age, sex and 
BMI, levels of both DHEA and DHEA-S predicted larger PGV (paths a), and larger PGV 
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was associated with increased symptoms of social anxiety (paths b). Neither the total effects 
of DHEA and DHEA-S on social anxiety symptoms (paths c, i.e., not controlling for PGV), 
nor the direct effects (paths c’, i.e., controlling for PGV) were significant. However, bias-
corrected 95% confidence intervals showed that larger PGV significantly partially mediated 
the relationships between increased DHEA and DHEA-S and greater symptoms of social 
anxiety (DHEA = CI: .004-.096, M = .036, SE = .023; DHEA-S = CI: .006-.108, M = .041, 
SE = .025) (Figures 3 and 4). That is, there was an indirect path from high DHEA/S to high 
social anxiety via larger PGV. Controlling for Tanner Stage did not change the pattern of 
significant results for any model. See Figure S1 in Supplementary Data for scatterplots 
illustrating bivariate associations between DHEA/S, PGV and social anxiety symptoms. 
To evaluate the specificity of the mediation effect to social anxiety, differences in the 
magnitude of the association between PGV and social versus other anxiety symptoms, 
controlling for DHEA or DHEA-S (and other covariates), were tested by comparing partial 
correlation coefficients using Steiger’s Z test (1-tailed; (Steiger, 1980). The association 
between PGV and social anxiety symptoms was significantly different to that for all other 
anxiety symptoms, with the exception of physical injury fears (DHEA: p = 0.067; DHEA-S; 
p = 0.061). 
 
-- insert Figure 3 about here -- 
-- insert Figure 4 about here -- 
  
3.4 Moderated Mediation Analyses 
Because moderated mediation is possible in the absence of simple mediation 
(Preacher & Hayes, 2004), the moderating role of sex in the initial mediation analysis was 
tested, with total anxiety scores on the SCAS. There was no significant moderated mediation; 
neither the interaction between DHEA and sex in the mediator model (B = -.035, SE = .036, t 
= -.951, p = .344), nor the interaction between PGV and sex in the dependent variable model 
(B = .205, SE = .800, t = .257, p = .798) were significant. When using DHEA-S as the 
independent variable, results were also non-significant; both the interaction between DHEA-
S and sex in the mediator model (B = -.021, SE = .032, t = -.667, p = .506), and the 
interaction between PGV and sex in the dependent variable model (B = .272, SE = .793, t = 
.343, p = .732) were non-significant.  
In subsequent moderated mediation analyses using social anxiety symptoms as the 
outcome variable, sex did not significantly moderate the indirect effect of DHEA on 
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symptoms of social anxiety through PGV; neither the interaction between DHEA and sex in 
the mediator model (B = -.035, SE = .036, t = -.951, p = .344), nor the interaction between 
PGV and sex in the dependent variable model (B = .708, SE = .764, t = .926, p = .357) was 
significant. No significant moderated mediation effect was demonstrated when using DHEA-
S as the independent variable; both the interaction between DHEA-S and sex in the mediator 
model (B = -.021, SE = .032, t = -.667, p = .506), and the interaction between PGV and sex in 
the dependent variable model (B = .714, SE = .761, t = .938, p = .351) were non-significant.  
In further exploratory analyses, the moderating role of sex was tested in mediation 
analyses with each of the other SCAS subscale scores as outcome variables. No significant 
moderated mediation effects were found for any of the SCAS subscales when controlling for 
BMI and age.  
 
3.5 Effects of Testosterone 
Given the strong associations between DHEA/S and testosterone, additional analyses 
were performed to assess the specificity of the above findings to DHEA/S. After controlling 
for testosterone levels (and other covariates, as above), the association between DHEA and 
PGV weakened and was no longer significant (path a: B = .031, SE = .026, t = 1.22, p = .225; 
controlling for Tanner Stage a: B = .031, SE = .026, t = 1.18, p = .240), whereas the 
association between DHEA-S and PGV remained significant (path a: B = .040, SE = .017, t = 
2.42, p = .018; controlling for Tanner Stage a: B = .037, SE = .017, t = 2.14, p = .035). In 
models where testosterone was the sole hormonal predictor, after controlling for other 
covariates, testosterone did not significantly predict PGV (path a: B = .098, SE = .052, t = 
1.88, p = .064; controlling for Tanner Stage a: B = .099, SE = .054, t = 1.83, p = .071). 
Combined, these results provide evidence for specificity of the effect of DHEA/S on PGV. 
3.6 Associations with Cortisol 
 In the whole sample, hair cortisol was negatively associated with physical injury fears 
(see Table 2), but was not significantly associated with any other variable. Exploratory partial 
correlational analyses (controlling for age and BMI) conducted separately by sex revealed 
significant and trend-level negative associations between cortisol and DHEA (r=-.70, 
p=.038), PGV (r=-.52, p=.052) and social anxiety (r=-.69, p=.038) in males only. 
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4. Discussion 
The precise neurobiological mechanisms linking adrenarcheal timing to symptoms of 
anxiety are currently unclear. We investigated whether relatively advanced adrenarcheal 
development (as indexed by high DHEA/S levels relative to age) was associated with larger 
pituitary gland volumes (PGV), and whether increased PGV mediated the link between early 
adrenarche and symptoms of anxiety in late childhood. The results of this unique study of 
adrenarcheal timing demonstrate that children with relatively high DHEA/S levels showed 
larger PGV. Whilst there was no direct effect of relative DHEA/S levels on general 
symptoms of anxiety, the results did support the role of PGV in mediating the link between 
relatively high DHEA/S levels and symptoms of social anxiety specifically. Interestingly, sex 
did not moderate this mediation effect, nor were there any sex differences in the relationship 
between DHEA/S and larger PGV. 
Results provide evidence that children whose adrenarcheal development is relatively 
early or mature demonstrate larger PGV than children whose adrenarcheal development is 
relatively late or immature. This is the first study of its kind to investigate the association 
between DHEA/S and PGV. That DHEA/S levels in children were found to be associated 
with larger PGV is consistent with the suggestion that the onset of adrenarche is associated 
with activation of the HPA axis, leading to increased volume and proliferation of corticotrope 
cells in the pituitary gland, which ultimately stimulate the function of the adrenal cortex 
(Axelson et al., 1992). These findings also suggest that the pituitary gland growth previously 
attributed to activation of the HPG axis and release of sex hormones during gonadarche (Kao, 
Cook, Hansen, & Simonson, 1992) likely commences prior to these processes, and is 
influenced by the activation of the HPA axis.  
Premature adrenarche has previously been associated with symptoms of anxiety 
(Dorn et al., 1999; Dorn et al., 2008; Sontag-Padilla et al., 2012). Whilst the results did not 
support a direct link between relatively high DHEA/S levels and anxiety symptoms, in 
exploratory analyses, an indirect link was found whereby larger PGV partially mediated the 
association between DHEA/S levels and social anxiety. Thus, the current findings may 
support the notion that neurobiological factors partly underlie previously reported links 
between early adrenarcheal timing and symptoms of anxiety in children. Further, these 
findings are consistent with research demonstrating that larger PGV predicts increased 
anxiety symptoms in early adolescence, both cross-sectionally and longitudinally (Zipursky 
et al., 2010). Of note, relatively early adrenarche, as defined in our study as high DHEA/S 
levels relative to age, should be differentiated from the clinical classification of premature 
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adrenarche. Our results suggest that adrenarche that is relatively early compared with peers, 
but not necessarily clinically abnormal, has implications for mental health. 
The exact mechanisms by which enlarged PGV might lead to increased symptoms of 
social anxiety are unclear. It has been suggested that the action of pubertal hormones on the 
development of the brain during sensitive periods may be responsible for dysregulated affect 
and behavior during puberty (Blakemore et al., 2010). We have previously found an indirect 
association between relatively high levels of adrenal hormones during adrenarche and 
symptoms of mental illness via brain function (Whittle et al., 2015). As such, it is possible 
that the current mediation findings suggest that relatively early exposure to adrenal hormones 
during adrenarche may affect pituitary function, which in turn, influences neural vulnerability 
to anxiety.  
The pituitary gland is an integral part of the HPA axis, whose activity also mediates 
circulating levels of stress hormones, including cortisol. While there is some evidence that 
HPA axis production of cortisol and DHEA/S are independent processes (for example, the 
increases in DHEA/S observed during adrenarche are not accompanied by similar increases 
in cortisol; Wolf & Kirschbaum, 1999), it is reasonable to speculate that DHEA/S and 
cortisol release may both be associated with pituitary gland volume, and that they may 
interact in some way. We conducted exploratory analyses to examine whether DHEA/S and 
PGV were associated with long-term cortisol levels in scalp hair. Although no associations 
were found in the whole sample, in males, higher levels of DHEA and larger PGV were both 
associated with lower cortisol levels; and, lower cortisol levels were associated with higher 
social anxiety symptoms. These results must be interpreted with caution, as only 11 males 
had cortisol data. Nonetheless, lower levels of hair cortisol might indicate a relative 
hypocortisolism, which has been associated with increased stress sensitivity (Fries, Hesse, 
Hellhammer, & Hellhammer, 2005). Further, it has been suggested that hypocortisolism and 
associated stress sensitivity might create a vulnerability for the future development of 
psychopathology (Heim, Newport, Mletzko, Miller, & Nemeroff, 2008). Indeed, other work 
supports an association between childhood anxiety and lower basal HPA axis function 
(Dieleman et al., 2014; Steudte et al., 2011). It is therefore possible that, at least in males, the 
relationship between increased pituitary volume and higher levels of social anxiety might 
reflect dysfunction of the HPA axis. We emphasize that this interpretation is speculative as it 
is based on a very small number of participants. Further research with larger numbers and 
assessment of long-term basal cortisol levels, in addition to cortisol reactivity is needed to 
comprehensively investigate function of the HPA axis as a potential mechanism linking 
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relatively early exposure to DHEA/S during adrenarche, PGV and anxiety. Indeed, there is 
other evidence that larger pituitary volumes are related to relatively higher activity and 
reactivity of the HPA axis (Kaess et al., 2013), and that hyper-reactivity of the HPA axis is 
associated with social anxiety (Condren, O'Neill, Ryan, Barrett, & Thakore, 2002).  
Interestingly, pituitary volume was found to partially mediate the relationship 
between DHEA/S levels and symptoms of social anxiety specifically. This may reflect the 
functional significance of pubertal development, which is thought to influence the 
development of social brain functions specifically due to the role of puberty in preparing the 
individual to enter into new types of social relationships (e.g., romantic relationships, 
competition for mates, Steinberg & Morris, 2000). Indeed, previous studies have 
demonstrated specific effects of pubertal development on neural measures of social emotion 
processing (Goddings, Burnett Heyes, Bird, Viner, & Blakemore, 2012). The current findings 
further suggest that, even at the early adrenarcheal phase of development, there may be some 
specificity in the relationship between the hormonal and neural changes occurring and social 
emotions.  
A possible mechanistic explanation for the mediatory effect of pituitary volume on 
symptoms specific to social anxiety comes from research linking HPA axis reactivity to stress 
and social avoidance (Sapolsky, 1990). An alternative explanation for the findings regarding 
social anxiety comes from research investigating the impact of premature adrenarche on 
executive function and psychopathology. Executive function represents the coordination of 
higher-order cognition and behavior, for example problem-solving, self-evaluation and 
regulation, and behavioral modulation. Executive function also promotes the development of 
social cognition, which may be particularly important in navigating difficult developmental 
transitions like puberty (Kolb & Fantie, 2009). Indeed, research has demonstrated consistent 
associations between less developed executive function and social and emotional problems 
(Miller & Hinshaw, 2010; Wahlstedt, Thorell, & Bohlin, 2008). Further, research has shown 
that children undergoing premature adrenarche perform more poorly on tasks of executive 
function than their normally developing peers (Dorn et al., 1999). It is therefore possible that 
children undergoing relatively early adrenarche may be at risk for social anxiety due to a 
potentially reduced ability to manage the affective and psychosocial demands of their 
environment. 
Interestingly, there were no sex differences in the associations between relative 
DHEA/S levels and pituitary volume, or pituitary volume and symptoms of anxiety. 
Neuroimaging research into structural brain development during gonadarche has reported sex 
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differences in global and regional grey and white matter to be associated with differential 
levels of sex hormones, including testosterone and estradiol (Peper et al., 2009; Peper et al., 
2008; Perrin et al., 2009). Further, research has demonstrated that the effects of sex hormones 
on PGV differ between boys and girls during gonadarche (Peper et al., 2010; Whittle et al., 
2012). The adrenal androgens (DHEA/S) are considered to be weak androgens, and act as 
precursors to the production of more potent estrogens and testosterone (Dorn et al., 1999). 
The plasma concentration of DHEA/S during adrenarche is also similar in boys and girls 
(Ilondo et al., 1982). Our results do suggest that while levels of DHEA/S influence pituitary 
volume during adrenarche, observable sex differences in pituitary volume may not emerge 
until gonadarche, as a result of the more potent sex hormones and their effects on the brain, 
but also increasing levels of DHEA/S through adolescence. 
The lack of sex differences in the associations between pituitary volume and 
symptoms of anxiety may also be a result of similar DHEA/S plasma concentration in boys 
and girls during adrenarche. It is also possible that pituitary volume during adrenarche is not 
an early precursor that underlies later sex differences in symptoms of anxiety and related 
disorders. Sex differences in these relationships might only emerge following the onset of 
gonadarche and differential exposure to potent sex hormones, when an increase in female 
vulnerability to anxiety symptoms and disorders become more pronounced (Slade, Johnston, 
Oakley Browne, Andrews, & Whiteford, 2009). We note our preliminary findings of a male-
specific association between DHEA, PGV, social anxiety and cortisol, which are suggestive 
of potential sex differences in the mechanisms underlying the observed results. Further 
research with larger samples is required to investigate this possibility. 
Our findings should be interpreted in light of the following limitations. First, we 
employed a cross-sectional design, which reduces the ability to make assumptions about the 
temporal ordering of effects. Although not part of the current theoretical model, it is plausible 
that pituitary volume may in fact influence the timing of DHEA/S production. Future work 
assessing baseline pituitary volumes before the onset of adrenarcheal processes would help to 
clarify this. Second, there may be other factors that are important in predicting levels of 
DHEA/S and cortisol, pituitary volume, and anxiety symptoms that we did not consider. For 
example, early life stress may be responsible for early adrenarche (Ellis & Essex, 2007) and 
larger PGV (Ganella et al., 2015), and thus might better explain the link between PGV and 
social anxiety (rather than this link being driven by early exposure to adrenal hormones). 
Future work should therefore incorporate measures of early life stress, as well as other factors 
like socioeconomic status and birth related factors, to explore their potential influences. 
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Third, we measured adrenarcheal timing by specifically selecting individuals who were 
matched for age but differed in their levels of DHEA/S. Although age was ultimately 
significantly correlated with DHEA/S, it was controlled for in all analyses, which allowed 
stronger conclusions to be drawn about relative timing of exposure to DHEA/S (i.e., 
adrenarcheal timing). However, further research is needed that measures changes in DHEA/S 
exposure over time, to investigate relationships amongst the variables in question more 
comprehensively. Fourth, relatively early adrenarche is likely to influence other brain regions 
and brain networks that were not investigated in the current study. For example, specific 
vulnerabilities during this developmental stage might represent the failure of HPA-axis 
control by prefrontal regions, which are undergoing dramatic developmental changes during 
this period (Herman et al., 2003; Sullivan & Gratton, 2002). These speculations require 
further investigation with measures of brain structure and function. Fifth, the main mediation 
findings of this study were based on exploratory correlational analyses; we had no specific 
hypothesis about social anxiety, specifically, from the outset. As such, these results should be 
interpreted with caution, and future research should aim to replicate the results in order to 
corroborate the findings. Indeed, there was some evidence that the findings were not specific 
to social anxiety (i.e., analyses suggested that PGV may also be associated with physical 
injury fears). Finally, the speculations regarding the role of stress and the HPA-axis in the 
link between pituitary volume and symptoms of anxiety require follow-up research given the 
small number of male participants for whom cortisol measures were available.  
5. Conclusions 
Our results provide evidence that PGV mediates the relationship between relatively 
early adrenarcheal timing and symptoms of social anxiety in children. This finding suggests 
that neurobiological mechanisms are partly responsible for the link between early 
adrenarcheal timing and increased symptoms of social anxiety. Further research is required to 
investigate the mechanisms by which an enlarged pituitary gland in children with relatively 
early exposure to DHEA/S may be associated with symptoms of social anxiety, including 
stress reactivity. Given that children with increased symptoms of anxiety are at risk for the 
development of depressive and anxiety disorders during adolescence and adulthood 
(Zipursky et al., 2010), these results may have implications for prevention and early 
intervention strategies during childhood. In particular, our findings suggest that the 
neurobiological vulnerabilities to adverse mental health outcomes that have been 
demonstrated in pubertally-advanced individuals emerge as early as adrenarche. Therefore, 
preventive strategies that target early maturing boys and girls with early symptoms of 
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anxiety, before they enter gonadarche, may be effective in preventing the onset of more 
clinically-significant mental health problems.  
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8. Figure legends 
 





Figure 2. Simple mediation model. Significant mediation is indicated if the a-b cross product 















Figure 3. Mediation analysis. Path a is the total effect of DHEA on pituitary volume, path b is 
the total effect of pituitary volume on symptoms of social anxiety, path c is the total effect of 
DHEA on symptoms of social anxiety (i.e., not controlling for pituitary volume), and path c’ 
is the direct effect of DHEA on symptoms of social anxiety (i.e., controlling for pituitary 




Figure 4. Mediation analysis. Path a is the total effect of DHEA-S on pituitary volume, path b 
is the total effect of pituitary volume on symptoms of social anxiety, path c is the total effect 
of DHEA-S on symptoms of social anxiety (i.e., not controlling for pituitary volume), and 
path c’ is the direct effect of DHEA-S on symptoms of social anxiety (i.e., controlling for 
pituitary gland volume).*p <0.05  
  
b: B = .912, SE = .378,  
t = 2.40, p = .018* 
a: B = .040, SE = .018,  
t = 2.21, p = .030* 
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c’: B = .011, SE = .066,  
t = .164, p = .870 
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a: B = .046, SE = .016,  
t = 2.97, p = .004* 
b: B = .894, SE = .388,  
t = 2.31, p = .024* 
c’: B = .016, SE = .059,  
t = .279, p = .781 
c: B = .057, SE = .057,  
t = 1.00, p = .319 
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9. Tables 
Table 1. Descriptive statistics for all variables and tests for sex differences.  
 Male (n=45) Female (n=50) Total t 
M (SD) M (SD) M (SD) 
Testosterone 
(pg/ml) 
44.71 (15.18) 48.28 (23.35) 46.59 (19.89) 0.86 
DHEA (pg/ml) 41.57 (30.92) 69.81 (96.98) 56.45 (74.53 1.85 
DHEA-S (pg/ml) 29.16 (42.59) 48.49 (106.40) 39.44 (83.05) 1.13 
Cortisol (pg/mg) 4.99 (3.54) 2.73 (2.51) 3.19 (2.86) 2.56* 
PGV 273.20 (49.89) 279.80 (62.18) 276.67 (56.50) 0.57 
SCAS Total 18.01 (10.22) 20.26 (12.48) 19.22 (11.47) 0.93 
   Separation 2.91 (2.51) 3.18 (2.60) 3.05 (2.55) 0.51 
   Social 2.91 (2.67) 4.04 (3.19) 3.51 (3.00) 1.85 
   OCD 4.34 (3.03) 3.58 (2.96) 3.94 (3.00) -1.22 
   Panic 1.89 (1.67) 1.82 (2.57) 1.85 (2.18) -1.46 
   Physical 2.45 (2.17) 3.50 (2.10) 3.01 (2.19 2.37* 
   GAD 3.50 (2.16) 4.16 (3.03) 3.85 (2.67) 1.20 
Age 9.57 (0.37) 9.42 (0.30) 9.50 (0.34) -
2.30* BMI 17.09 (1.90) 18.04 (2.51) 17.6 (2.28) 2.08* 
*p <0.05  
Note. BMI = Body Mass Index; PGV = Pituitary Gland Volume; DHEA = 
Dehydroepiandroesterone; DHEAS = Dehydroepiandrosterone-sulphate; SCAS Total = Total 
score on the Spence Children’s Anxiety Scale; Separation = SCAS Separation Anxiety 
subscale; Social = SCAS Social Anxiety subscale; OCD = SCAS Obsessive Compulsive 
Disorder subscale; Panic = SCAS Panic and Agoraphobia subscale; Physical = SCAS 
Physical Injury subscale; GAD = SCAS Generalized Anxiety subscale.  
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Table 2. Bivariate correlations between all variables.  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Sex               
2. Age .23*              
3. BMI -.21* .19             
4. PGV -.05 .13 .19            
5. DHEA -.05 .24* .38** .28**           
6. DHEA-S -.03 .21* .21* .32** .56**          
7. TST -.04 .14 .34** .24* .75** .44**         
8. SCAS Total -.08 .07 .11 .11 .10 .15 -.01        
9. Separation -.062 .025 -.00 -.07 -.03 .07 -.09 .76**       
10. Social -.22* .10 .14 .29** .14 .16 .014 .82** .56**      
11. OCD .13 .08 .08 .10 .03 .09 -.05 .71** .43** .53**     
12. Panic .12 .13 -.03 .08 .16 .13 .09 .59** .54** .45** .32**    
13. Physical -.30** .00 .20 .11 .03 .08 -.01 .58** .41** .54** .32** .17   
14. GAD -.10 .02 .16 .13 .17 .17 .12 .71** .42** .55** .44** .38** .35**  
15. Cortisol .34* .12 -.26 .02 -.16 .11 -.04 -.18 -.08 -.18 -.08 -.04 -.39** -.06 
*Correlation significant at p <.05 (2-tailed). **Correlation significant at p <.01 (2-tailed). 
Note. BMI = Body Mass Index; PGV = Pituitary Gland Volume; DHEA = Dehydroepiandroesterone; DHEAS = Dehydroepiandrosterone-
sulphate; TST = Testosterone; SCAS Total  = Total score on the Spence Children’s Anxiety Scale; Separation = SCAS Separation Anxiety 
subscale; Social = SCAS Social Anxiety subscale; OCD = SCAS Obsessive Compulsive Disorder subscale; Panic = SCAS Panic and 
Agoraphobia subscale; Physical = SCAS Physical Injury subscale; GAD = SCAS Generalized Anxiety subscale 
